Literature DB >> 28275163

Axonal Degeneration in Retinal Ganglion Cells Is Associated with a Membrane Polarity-Sensitive Redox Process.

Mohammadali Almasieh1,2, Maria-Magdalena Catrinescu1, Loïc Binan1, Santiago Costantino1, Leonard A Levin3,2,4.   

Abstract

Axonal degeneration is a pathophysiological mechanism common to several neurodegenerative diseases. The slow Wallerian degeneration (WldS) mutation, which results in reduced axonal degeneration in the central and peripheral nervous systems, has provided insight into a redox-dependent mechanism by which axons undergo self-destruction. We studied early molecular events in axonal degeneration with single-axon laser axotomy and time-lapse imaging, monitoring the initial changes in transected axons of purified retinal ganglion cells (RGCs) from wild-type and WldS rat retinas using a polarity-sensitive annexin-based biosensor (annexin B12-Cys101,Cys260-N,N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylenediamine). Transected axons demonstrated a rapid and progressive change in membrane phospholipid polarity, manifested as phosphatidylserine externalization, which was significantly delayed and propagated more slowly in axotomized WldS RGCs compared with wild-type axons. Delivery of bis(3-propionic acid methyl ester)phenylphosphine borane complex, a cell-permeable intracellular disulfide-reducing drug, slowed the onset and velocity of phosphatidylserine externalization in wild-type axons significantly, replicating the WldS phenotype, whereas extracellular redox modulation reversed the WldS phenotype. These findings are consistent with an intra-axonal redox mechanism for axonal degeneration associated with the initiation and propagation of phosphatidylserine externalization after axotomy.SIGNIFICANCE STATEMENT Axonal degeneration is a neuronal process independent of somal apoptosis, the propagation of which is unclear. We combined single-cell laser axotomy with time-lapse imaging to study the dynamics of phosphatidylserine externalization immediately after axonal injury in purified retinal ganglion cells. The extension of phosphatidylserine externalization was slowed and delayed in Wallerian degeneration slow (WldS) axons and this phenotype could be reproduced by intra-axonal disulfide reduction in wild-type axons and reversed by extra-axonal reduction in WldS axons. These results are consistent with a redox mechanism for propagation of membrane polarity asymmetry in axonal degeneration.
Copyright © 2017 the authors 0270-6474/17/373824-16$15.00/0.

Entities:  

Keywords:  Wallerian degeneration slow; axon membrane; axonal degeneration; phosphatidylserine; redox

Mesh:

Year:  2017        PMID: 28275163      PMCID: PMC5394899          DOI: 10.1523/JNEUROSCI.3882-16.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  92 in total

Review 1.  Axonal self-destruction and neurodegeneration.

Authors:  Martin C Raff; Alan V Whitmore; John T Finn
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

2.  WldS and PGC-1α regulate mitochondrial transport and oxidation state after axonal injury.

Authors:  Kelley C O'Donnell; Mauricio E Vargas; Alvaro Sagasti
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

3.  Cell survival or cell death: differential vulnerability of long descending and thoracic propriospinal neurons to low thoracic axotomy in the adult rat.

Authors:  A C Conta Steencken; I Smirnov; D J Stelzner
Journal:  Neuroscience       Date:  2011-05-31       Impact factor: 3.590

4.  A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.

Authors:  Robert Adalbert; Thomas H Gillingwater; Jane E Haley; Katherine Bridge; Bogdan Beirowski; Livia Berek; Diana Wagner; Daniela Grumme; Derek Thomson; Arzu Celik; Klaus Addicks; Richard R Ribchester; Michael P Coleman
Journal:  Eur J Neurosci       Date:  2005-01       Impact factor: 3.386

Review 5.  Annexins: linking Ca2+ signalling to membrane dynamics.

Authors:  Volker Gerke; Carl E Creutz; Stephen E Moss
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

6.  Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats.

Authors:  M P Villegas-Pérez; M Vidal-Sanz; M Rasminsky; G M Bray; A J Aguayo
Journal:  J Neurobiol       Date:  1993-01

7.  Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma.

Authors:  Judy V Nguyen; Ileana Soto; Keun-Young Kim; Eric A Bushong; Ericka Oglesby; Francisco J Valiente-Soriano; Zhiyong Yang; Chung-ha O Davis; Joseph L Bedont; Janice L Son; John O Wei; Vladimir L Buchman; Donald J Zack; Manuel Vidal-Sanz; Mark H Ellisman; Nicholas Marsh-Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-03       Impact factor: 11.205

Review 8.  The distribution and function of phosphatidylserine in cellular membranes.

Authors:  Peter A Leventis; Sergio Grinstein
Journal:  Annu Rev Biophys       Date:  2010       Impact factor: 12.981

9.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

10.  Live Imaging of Calcium Dynamics during Axon Degeneration Reveals Two Functionally Distinct Phases of Calcium Influx.

Authors:  Mauricio Enrique Vargas; Yuya Yamagishi; Marc Tessier-Lavigne; Alvaro Sagasti
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

View more
  12 in total

Review 1.  The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Biochem Soc Trans       Date:  2018-03-09       Impact factor: 5.407

Review 2.  Die in pieces: How Drosophila sheds light on neurite degeneration and clearance.

Authors:  Maria L Sapar; Chun Han
Journal:  J Genet Genomics       Date:  2019-04-23       Impact factor: 4.275

Review 3.  Axonal spheroids in neurodegeneration.

Authors:  Yu Yong; Sarah Hunter-Chang; Ekaterina Stepanova; Christopher Deppmann
Journal:  Mol Cell Neurosci       Date:  2021-10-19       Impact factor: 4.314

Review 4.  Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

Review 5.  Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases.

Authors:  Cinzia Rapino; Daniel Tortolani; Lucia Scipioni; Mauro Maccarrone
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  Phosphatidylserine Externalization Results from and Causes Neurite Degeneration in Drosophila.

Authors:  Maria L Sapar; Hui Ji; Bei Wang; Amy R Poe; Kush Dubey; Xingjie Ren; Jian-Quan Ni; Chun Han
Journal:  Cell Rep       Date:  2018-08-28       Impact factor: 9.423

7.  Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma.

Authors:  Michal Geva; Noga Gershoni-Emek; Luana Naia; Philip Ly; Sandra Mota; Ana Cristina Rego; Michael R Hayden; Leonard A Levin
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

Review 8.  Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

9.  Phosphatidylserine is a marker for axonal debris engulfment but its exposure can be decoupled from degeneration.

Authors:  Vered Shacham-Silverberg; Hadas Sar Shalom; Ron Goldner; Yarden Golan-Vaishenker; Neta Gurwicz; Irena Gokhman; Avraham Yaron
Journal:  Cell Death Dis       Date:  2018-11-02       Impact factor: 8.469

Review 10.  Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1.

Authors:  Kenneth Maiese
Journal:  Neural Regen Res       Date:  2021-03       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.